Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Revista Colombiana de Cancerología
Print version ISSN 0123-9015
Abstract
MARTI SAMPER, Alejandro. High risk melanoma re-staged with F-18-FDG-PET/CT. rev.colomb.cancerol. [online]. 2014, vol.18, n.4, pp.202-205. ISSN 0123-9015. https://doi.org/10.1016/j.rccan.2014.04.004.
The melanoma is the most common form of deadly skin cancer, with an incidence that is increasing faster than any other type of potentially preventable cancer. The survival rates at five years for people with melanoma depends on the stage of the disease at diagnosis. Survival decreases as the thickness of the tumor and the stage of the disease increases. Most people with stage I lesions can expect disease free survival and even cure, while those with thicker lesions located in the more advanced stages are more likely to die from metastatic disease. Clinical, laboratory and imaging studies are needed to accurately stage these patients before definitive treatment. The use of diagnostic imaging such as positron emission tomography (PET) in patients at high risk provides an indispensable complement to the clinical staging.
Keywords : Positron emission tomography; Melanoma; Staging.